Stock OMGA OMEGA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Omega Therapeutics, Inc.

Equities

OMGA

US68217N1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.33 USD -0.43% Intraday chart for Omega Therapeutics, Inc. -8.81% -22.59%
Apr. 16 Omega Therapeutics CFO Joshua Reed to Depart MT
Apr. 16 Omega Therapeutics, Inc. Announces Executive Changes, Effective as of May 31, 2024 CI

Evolution of the average Target Price on Omega Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f83a81665713.q3AQ1mmkldsY0fpfPYCX8vh4anCc3B51oxxenANqNZ8.7CdyoyyJoJ1TvI9vRM7zgspPCQTZql8xmis2_0gwatDSMX-fOMnD9nTksw~c5a5a1fc9ae23bd9b36f45395a56d637

Analyst Recommendations on Omega Therapeutics, Inc.

Piper Sandler Trims Price Target on Omega Therapeutics to $9 From $10, Maintains Overweight Rating MT
Chardan Cuts Price Target on Omega Therapeutics to $7 From $12, Keeps Buy Rating MT
HC Wainwright Adjusts Omega Therapeutics' Price Target to $12 From $11, Maintains Buy Rating MT
Wedbush Lowers Omega Therapeutics' PT to $12 From $19, Adjusts Financing Assumptions; Keeps Outperform Rating MT
Wedbush Lowers Omega Therapeutics' Price Target to $19 From $23, Adjusts Financing Assumptions; Keeps Outperform Rating MT
JonesTrading Initiates Omega Therapeutics at Buy With $11 Price Target MT
Piper Sandler Adjusts Omega Therapeutics' Price Target to $10 From $8, Keep Overweight Rating MT
Wedbush Cuts Omega Therapeutics's Price Target to $23 From $25, Maintains Outperform Rating MT
HC Wainwright Initiates Omega Therapeutics With Buy Rating, Sets Price Target at $11 MT
Wedbush Lifts Omega Therapeutics' Price Target to $25 From $24, Keeps Outperform Rating MT
Chardan Starts Omega Therapeutics at Buy With $12 Price Target MT
Goldman Sachs Adjusts Price Target for Omega Therapeutics to $4 From $7, Retains Neutral Rating MT
Piper Sandler Lowers Omega Therapeutics' Price Target to $7 From $30, Maintains Overweight Rating MT
Wedbush Adjusts Price Target on Omega Therapeutics to $24 From $30, Keeps Outperform Rating MT
Wedbush Adjusts Omega Therapeutics' Price Target to $30 From $36, Keeps Outperform Rating MT
OMEGA THERAPEUTICS : Jefferies Starts Omega Therapeutics at Buy With $30 Price Target MT
OMEGA THERAPEUTICS : Goldman Sachs Starts Omega Therapeutics at Neutral With $22 Price Target MT
OMEGA THERAPEUTICS : Piper Sandler Starts Omega Therapeutics at Overweight With $30 Price Target MT
OMEGA THERAPEUTICS : Wedbush Starts Omega Therapeutics at Outperform With $36 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.33 USD
Average target price
11 USD
Spread / Average Target
+372.10%
High Price Target
15 USD
Spread / Highest target
+543.78%
Low Price Target
7 USD
Spread / Lowest Target
+200.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Omega Therapeutics, Inc.

Piper Sandler
Chardan Research
HC Wainwright
Wedbush
JonesTrading Institutional Services
Goldman Sachs
Jefferies & Co.

Ratings for Omega Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OMGA Stock
  4. Consensus Omega Therapeutics, Inc.